Hai-O Enterprise Berhad operates in the Drugs, proprietaries, and sundries sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Hai-O Enterprise Berhad with three other
drug stores in Asia:
Hin Sang Group International Holding Co Ltd
of Hong Kong
sales of 227.46 million Hong Kong Dollars [US$29.33 million]
of which 81%
was Product Development Segment),
Hong Kong Life Sciences and Technologies Group Ltd
of Hong Kong
(123.37 million Hong Kong Dollars [US$15.91 million]
of which 77%
was Trading Business), and
Extrawell Pharmaceutical Holdings Limited
based in Hong Kong
(142.20 million Hong Kong Dollars [US$18.33 million]
of which 70%
Hai-O Enterprise Berhad reported sales of 297.63 million Malaysian Ringgits (US$67.09 million)
April of 2016.
increase of 24.1%
versus 2015, when the company's sales were 239.85 million Malaysian Ringgits.
Sales of Multi-Level Marketing saw an increase
46.3% in 2016, from
135.56 million Malaysian Ringgits to 198.28 million Malaysian Ringgits.
Not all segments of Hai-O Enterprise Berhad experienced an increase in sales in 2016:
sales of Retail fell 5.7% to 38.31 million Malaysian Ringgits.
Hai-O Enterprise Berhad also experienced decreases in sales in
Wholesale (down 3.9% to 54.36 million Malaysian Ringgits)
Others (down 5.5% to 6.69 million Malaysian Ringgits)